• Profile
Close

Dr. Reddy’s Lab launches Chlorthalidone tablets, USP in US market

UNI Nov 29, 2018

Hyderabad-based Dr Reddy’s Laboratories Ltd, along with its subsidiaries together referred to as 'Dr Reddy’s' on November 28 announced the launch of Chlorthalidone Tablets USP, a therapeutic equivalent generic version of Hygroton (chlorthalidone) Tablets, in US market.



The drug was approved by the US Food and Drug Administration (USFDA), the major pharmaceutical company said in release at Hyderabad. The Hygroton brand and generic had US sales of approximately $122 million MAT for the most recent twelve months ending in September 2018 according to IMS Health. Dr Reddy’s Chlorthalidone Tablets, USP are available in 25 mg tablets in the bottle-count sizes of 100 and 1000, and 50 mg tablets in the bottle-count size of 100.

Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay